GLP-1 Medications and Pregnancy: Important Safety Information

This article contains affiliate links. GLP01 (operated by SwipeClick LLC) may receive compensation when you visit third-party providers through our links.

Understanding the relationship between GLP-1 medications and pregnancy is critical for anyone of reproductive age considering or currently using these treatments. GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are not recommended during pregnancy, and specific precautions are necessary before, during, and after potential conception. This guide covers the essential safety information about GLP-1 medications and pregnancy that every patient should know.

The Bottom Line: GLP-1 Medications and Pregnancy

GLP-1 medications should not be used during pregnancy. Here's what the FDA and manufacturers recommend:

• Semaglutide (Ozempic, Wegovy): Discontinue at least 2 months before a planned pregnancy
• Tirzepatide (Mounjaro, Zepbound): Specific washout periods should be discussed with your provider; manufacturer recommendations may vary
• All GLP-1 medications: Report any pregnancy to your healthcare provider immediately and discontinue the medication

These recommendations exist because the potential effects on a developing fetus are not well-established, and animal studies have raised concerns.

What Animal Studies Show

The safety concerns around GLP-1 medications in pregnancy are largely based on animal research:

Semaglutide Animal Data

• Studies in rats showed increased pregnancy loss and birth defects when exposed to semaglutide during development
• Effects were observed at doses relevant to human use (based on body surface area comparisons)
• Reduced fetal growth was also observed
• These findings contributed to the FDA's pregnancy warning

Tirzepatide Animal Data

• Animal studies similarly showed adverse developmental effects
• Pregnancy loss and skeletal variations were observed in animal models
• These findings support the recommendation against use during pregnancy

Limitations of Animal Data

• Animal studies don't always predict human effects — humans may respond differently
• However, the precautionary principle applies: when animal data suggests risk and human data is limited, avoidance during pregnancy is the appropriate approach
• There are no adequate, well-controlled studies of GLP-1 medications in pregnant humans

The Fertility Paradox: GLP-1 May Increase Fertility

One of the most important — and sometimes surprising — effects of GLP-1 medications is their potential impact on fertility:

How GLP-1 Medications May Affect Fertility

• Weight loss improves ovulation: Excess weight is associated with irregular or absent ovulation. Weight loss from GLP-1 medications may restore ovulatory cycles
• Improved insulin sensitivity: Particularly relevant for women with PCOS, improved insulin function may normalize reproductive hormones
• Hormonal rebalancing: Reduced body fat may lead to lower excess estrogen and improved follicle-stimulating hormone (FSH) balance
• Reports of unexpected pregnancies: Healthcare providers have reported cases of patients conceiving unexpectedly after starting GLP-1 medications — sometimes referred to as "Ozempic babies" in popular media

The Contraception Conversation

This fertility-enhancing effect creates an important clinical scenario:

• Women who previously had difficulty conceiving may suddenly become fertile on GLP-1 medications
• If pregnancy is not desired, effective contraception is essential
• Oral contraceptives may be affected: GLP-1 medications slow gastric emptying, which could theoretically alter absorption of oral medications, including birth control pills
• Discuss contraception options with your healthcare provider when starting GLP-1 therapy
• Non-oral contraception methods (IUDs, implants, injections) are not affected by gastric emptying changes

Planning for Pregnancy While on GLP-1 Medications

If you're on a GLP-1 medication and want to become pregnant, careful planning is essential:

Step 1: Talk to Your Provider First

Before trying to conceive, discuss your plans with your healthcare provider. They will help you:

• Determine the appropriate timeline for discontinuing your medication
• Plan for the washout period
• Develop a strategy for weight maintenance during the transition
• Address any underlying conditions (like PCOS or type 2 diabetes) that may need alternative management
• Evaluate your overall health and readiness for pregnancy

Step 2: Medication Washout Period

The washout period allows the medication to clear your system:

• Semaglutide: At least 2 months before planned conception (the half-life is approximately 1 week, and 5 half-lives — about 5 weeks — are needed for near-complete clearance)
• Tirzepatide: Discuss specific timing with your provider
• Liraglutide: Shorter half-life means potentially shorter washout, but discuss with your provider

Step 3: Transition Plan

During the transition off GLP-1 medication:

• Weight management: Have a plan for maintaining weight loss without the medication's appetite-suppressing effects
• Blood sugar management (if diabetic): Transition to pregnancy-safe diabetes medications under medical guidance
• Nutritional optimization: Begin prenatal vitamins, ensure adequate folate intake, and optimize nutrition for pregnancy
• Lifestyle habits: Strengthen exercise and dietary habits that will support pregnancy

Step 4: Pre-Conception Health

Optimize your health for pregnancy:

• Start prenatal vitamins (with folic acid) at least 1 month before trying to conceive
• Achieve stable blood sugar levels if diabetic
• Complete recommended health screenings
• Discuss any concerns with both your prescribing provider and your OB-GYN

What If You Become Pregnant While on a GLP-1 Medication?

If you discover you're pregnant while taking a GLP-1 medication:

1. Stop the medication immediately and contact your healthcare provider
2. Don't panic — many early pregnancies are exposed to medications before the pregnancy is known, and exposure doesn't guarantee harm
3. Seek early prenatal care to monitor the pregnancy closely
4. Inform your OB-GYN about the medication exposure, including the drug name, dose, and duration of use
5. Follow your provider's guidance for monitoring and any additional testing that may be recommended

Reporting Pregnancy Exposures

• Manufacturers maintain pregnancy registries to track outcomes of pregnancies exposed to their medications
• Your provider may encourage reporting to these registries, which helps build the safety database
• The FDA's MedWatch program also accepts reports

Breastfeeding and GLP-1 Medications

The safety of GLP-1 medications during breastfeeding is also not well-established:

• Limited data: There's insufficient information about whether semaglutide or tirzepatide passes into breast milk
• Animal studies: In animal studies, semaglutide has been found in breast milk
• Clinical guidance: Most providers recommend against using GLP-1 medications while breastfeeding
• Risk-benefit discussion: If weight management medication is desired during breastfeeding, discuss alternative options with your provider

Weight Management During Pregnancy (Without GLP-1 Medications)

After discontinuing GLP-1 medication for pregnancy, weight management becomes more nuanced:

Healthy Approaches

• Balanced nutrition: Focus on nutrient-dense foods that support fetal development
• Appropriate weight gain: Follow your OB-GYN's guidance for healthy pregnancy weight gain based on your pre-pregnancy BMI
• Regular, moderate exercise: Most pregnant women can safely engage in moderate exercise with provider approval
• Blood sugar monitoring: Especially important if you have type 2 diabetes or develop gestational diabetes

What's NOT Recommended During Pregnancy

• Intentional weight loss (for most women)
• Severe caloric restriction
• Any weight loss medication
• Extreme exercise programs

After Pregnancy: Returning to GLP-1 Medications

Many women are interested in resuming GLP-1 medications after pregnancy:

Timing Considerations

• If not breastfeeding: Your provider may consider restarting a GLP-1 medication during the postpartum period
• If breastfeeding: Wait until breastfeeding is complete (or discuss the risk-benefit with your provider)
• Postpartum health: Ensure you're medically stable and have had appropriate postpartum evaluation
• Dose restart: You'll likely need to begin the dose titration schedule again from the starting dose

Postpartum Weight Management

• Many women retain weight after pregnancy
• GLP-1 medications, when safe to resume, could help address postpartum weight retention
• Discuss timing with both your prescribing provider and your OB-GYN

For Men: GLP-1 Medications and Male Fertility

While much of the pregnancy discussion focuses on women, men should be aware of potential considerations:

• Current evidence does not suggest GLP-1 medications significantly impair male fertility
• Some research suggests that weight loss and improved metabolic health may actually benefit male fertility
• Testosterone levels may improve with weight loss in men with obesity
• Men taking GLP-1 medications are generally not required to stop before their partner attempts conception
• However, discuss any fertility concerns with your healthcare provider

Frequently Asked Questions

Can GLP-1 medications cause birth defects?

Animal studies have shown developmental effects including birth defects and pregnancy loss when exposed to GLP-1 medications. However, there is limited human data. The precautionary approach is to avoid these medications during pregnancy and observe the recommended washout period before attempting conception. If you were exposed early in pregnancy before knowing you were pregnant, consult your healthcare provider for personalized guidance.

How long before trying to conceive should I stop Ozempic/Wegovy?

Novo Nordisk recommends discontinuing semaglutide at least 2 months before a planned pregnancy. This allows time for the medication to clear your system. Your healthcare provider may recommend additional time depending on your specific circumstances.

Can Ozempic help me get pregnant?

While not FDA-approved for fertility enhancement, the weight loss and metabolic improvements associated with GLP-1 medications may improve fertility in some women — particularly those with PCOS or obesity-related ovulatory dysfunction. Some healthcare providers have observed patients conceiving after starting GLP-1 medications. However, the medication must be discontinued before pregnancy is attempted.

What should I use for birth control while on GLP-1 medications?

Discuss contraception with your provider. Because GLP-1 medications slow gastric emptying, there is a theoretical concern about reduced absorption of oral contraceptives (birth control pills). Non-oral methods like IUDs, implants, injections (Depo-Provera), or barrier methods are not affected by gastric emptying changes and may be more reliable options.

Is it safe to breastfeed while taking GLP-1 medications?

This is not definitively answered by current research. Animal studies have shown semaglutide passes into breast milk, and there is insufficient human data. Most healthcare providers recommend against using GLP-1 medications while breastfeeding. Discuss the risks and benefits with your provider if postpartum weight management is a priority.

Taking the Next Step

If you're of reproductive age and considering GLP-1 medications, having an informed conversation with your healthcare provider about family planning is essential. These medications can be powerful tools for weight management, but proper planning around pregnancy ensures the safety of both you and any future pregnancy.

Ready to explore your options? Take our free eligibility quiz → to learn about GLP-1 medications and whether they may be appropriate for you. Connect with a licensed telehealth provider who can discuss the intersection of weight management, fertility, and reproductive health planning.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication, especially if you are pregnant, planning pregnancy, or breastfeeding.

GLP01 is operated by SwipeClick LLC, a marketing company — not a healthcare provider. Telehealth services and medication availability may vary by state.